Univ.-Prof. Dr. Christopher Gerner
T: +43-1-4277-52302
Wintersemester 2019
270013 SE Erstellen der Bachelorarbeit B - Analytische Chemie + Lebensmittelchemie
270103 PR Wahlfachpraktikum B (Bachelormodul) - Analytische Chemie + Lebensmittelchemie
270235 SE Analytisch-chemisches Seminar (Institutsseminar) - insbesondere für Dissertanten und Diplomanden
Sommersemester 2019
270013 SE Erstellen der Bachelorarbeit B - Analytische Chemie + Lebensmittelchemie
270016 VO Massenspektrometrie - Moderne Instrumentierung, Methoden und Anwendungen
270030 SE Analytisch-chemisches Seminar (Institutsseminar) - insbesondere für Dissertanten und Diplomanden (Institutsseminar)
270103 PR Wahlfachpraktikum B (Bachelormodul) - Analytische Chemie + Lebensmittelchemie
270130 UE Spektroskopisches Praktikum - UV/VIS,IR/RAMAN,NMR
Wintersemester 2018
270013 SE Erstellen der Bachelorarbeit B - Analytische Chemie + Lebensmittelchemie
270103 PR Wahlfachpraktikum B (Bachelormodul) - Analytische Chemie + Lebensmittelchemie
270130 UE Spektroskopisches Praktikum - UV/VIS,IR/RAMAN,NMR
270235 SE Analytisch-chemisches Seminar (Institutsseminar) - insbesondere für Dissertanten und Diplomanden



Kreutz, D, Gerner, C & Meier-Menches, SM 2019, Enabling Methods to Elucidate the Effects of Metal-based Anticancer Agents. in A Vessieres, SM Meier-Menches & A Casini (Hrsg.), Metal-based Anticancer Agents . RSC Metallobiology, Nr. 14, Bd. 2019-January, Royal Society of Chemistry, S. 246-270. https://doi.org/10.1039/9781788016452-00246









Heudobler, D, Rechenmacher, M, Lueke, F, Vogelhuber, M, Klobuch, S, Thomas, S, Pukrop, T, Hackl, C, Herr, W, Ghibelli, L, Gerner, C & Reichle, A 2018, 'Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis', Frontiers in Pharmacology, Jg. 9, 1357. https://doi.org/10.3389/fphar.2018.01357

Niederstätter, L, Hedesan, OC, Herz, C, Haug, AR, Gerner, C & Kiefer, FW 2018, 'Cold induced eicosanoid signature differs between BAT positive and BAT negative subjects', Dortmund, Deutschland, 11/11/18 - 13/11/18, .

Heudobler, D, Rechenmacher, M, Lueke, F, Vogelhuber, M, Pukrop, T, Herr, W, Ghibelli, L, Gerner, C & Reichle, A 2018, 'Peroxisome Proliferator-Activated Receptors (PPAR) Agonists as Master Modulators of Tumor Tissue', International Journal of Molecular Sciences, Jg. 19, Nr. 11, 3540. https://doi.org/10.3390/ijms19113540

Schwarzmeier, J, Gerner, C, Slany, A, Mayer, RL, Gerner, MC & Reichle, A 2018, 'Aging von Lymphozyten als mögliche Prädisposition zur chronisch lymphatischen Leukämie? Proteomische und metabolomische Analysen', Wien, Österreich, 28/09/18 - 2/10/18, .

Niederstätter, L, Hedesan, OC, Herz, C, Haug, AR, Gerner, C & Kiefer, FW 2018, Cold induced eicosanoid signature differs between BAT positive and BAT negative subjects. in M Fedorova (Hrsg.), Conference Proceedings., Leipzig, Deutschland, 26/09/18.





Ribitsch, I, Mayer, RL, Egerbacher, M, Gabner, S, Kandula, MM, Rosser, J, Haltmayer, E, Auer, U, Gueltekin, S, Huber, J, Bileck, A, Kreil, DP, Gerner, C & Jenner, F 2018, 'Fetal articular cartilage regeneration versus adult fibrocartilaginous repair: secretome proteomics unravels molecular mechanisms in an ovine model', Disease models & mechanisms, Jg. 11, Nr. 7, 033092. https://doi.org/10.1242/dmm.033092


Oikonomidi, I, Burbridge, E, Cavadas, M, Sullivan, G, Collis, B, Naegele, H, Clancy, D, Brezinova, J, Hu, T, Bileck, A, Gerner, C, Bolado, A, von Kriegsheim, A, Martin, SJ, Steinberg, F, Strisovsky, K & Adrain, C 2018, 'iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE', eLife, Jg. 7, 35032. https://doi.org/10.7554/eLife.35032

Kreutz, D, Sinthuvanich, C, Bileck, A, Janker, L, Slany, A & Gerner, C 2018, Curcumin exerts its antitumor effects in a context dependent fashion. in Book of Abstracts., Rom, Italien, 19/04/18.

Niederstätter, L, Gerner, MC, Bileck, A, Slany, A, Schmetterer, K & Gerner, C 2018, Immune cells strategies for coping with metabolic stress as cancer model. in Book of Abstracts., Rom, Italien, 19/04/18.

Gerner, C, Bachmayr-Heyda, A, Aust, S, Niederstätter, L, Neuditschko, B, Janker, L, Muqaku, B & Pils, D 2018, Integrative Metabolomics with Impact on Survival in Serous Ovarian Cancer. in Book of Abstracts., Rom, Italien, 19/04/18.

Muqaku, B, Eisinger, M, Meier-Menches, SM, Tahir, A, Pukrop, T, Haferkamp, S, Slany, A, Reichle, A & Gerner, C 2018, Reprogramming of organ functions via systemic calcium mobilization. in Book of Abstracts., Rom, Italien, 19/04/18.

Al-Serori, H, Ferk, F, Kundi, M, Bileck, A, Gerner, C, Misik, M, Nersesyan, A, Waldherr, M, Murbach, M, Lah, TT, Herold-Mende, C, Collins, AR & Knasmueller, S 2018, 'Mobile phone specific electromagnetic fields induce transient DNA damage and nucleotide excision repair in serum-deprived human glioblastoma cells', PLoS ONE, Jg. 13, Nr. 4, e0193677. https://doi.org/10.1371/journal.pone.0193677






Heudobler, D, Rechenmacher, M, Vogelhuber, M, Thomas, S, Pukrop, T, Hackl, C, Herr, W, Ghibelli, L, Gerner, C & Reichle, A 2018, 'A novel therapeutic pillar, anakoinosis: Tumor tissue as a multi-level design space, a meta-analysis', Oncology Research and Treatment, Jg. 41, S. 316-316.

Aust, S, Bachmayr-Heyda, A, Auer, K, Meier-Menches, SM, Schmetterer, K, Dekan, S, Gerner, C & Pils, D 2017, 'IMPACT ON SURVIVAL OF INTEGRATIVE SYSTEMIC AND LOCAL METABOLOMICS IN HIGH-GRADE SEROUS OVARIAN CANCER', International Journal of Gynecological Cancer, Jg. 27, Nr. Supplement 4 , ESGO7-1011, S. 335-335. https://doi.org/10.1097/01.IGC.0000527296.86225.87

Aust, S, Bachmayr-Heyda, A, Auer, K, Meier, S, Schmetterer, K, Dekan, S, Gerner, C & Pils, D 2017, 'IMPACT ON SURVIVAL OF INTEGRATIVE SYSTEMIC AND LOCAL METABOLOMICS IN HIGH-GRADE SEROUS OVARIAN CANCER', International Journal of Gynecological Cancer, Jg. 27, S. 1798-1798.

Cavadas, M, Oikonomidi, I, Gaspar, CJ, Burbridge, E, Badenes, M, Felix, I, Bolado, A, Hu, T, Bileck, A, Gerner, C, Domingos, PM, von Kriegsheim, A & Adrain, C 2017, 'Phosphorylation of iRhom2 Controls Stimulated Proteolytic Shedding by the Metalloprotease ADAM17/TACE', Cell Reports, Jg. 21, Nr. 3, S. 745-757. https://doi.org/10.1016/j.celrep.2017.09.074














Gerner, C, Meier, SM, Kreutz, D, Weiss, T, Bileck, A, Keppler, B & Wiche, G 2017, On the molecular mechanism of action of organometallic anticancer drugs. in Book of Abstracts., Wien, Österreich, 14/08/17.

Meier, SM, Kreutz, D, Winter, L, Klose, MHM, Cseh, K, Weiss, T, Bileck, A, Alte, B, Mader, JC, Jana, S, Chatterjee, A, Bhattacharyya, A, Hejl, M, Jakupec, MA, Heffeter, P, Berger, W, Hartinger, CG, Keppler, BK, Wiche, G & Gerner, C 2017, 'An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin', Angewandte Chemie (International Edition), Jg. 56, Nr. 28, S. 8267-8271. https://doi.org/10.1002/anie.201702242




Weiss, T, Taschner-Mandl, S, Bileck, A, Slany, A, Rifatbegovic, F, Dodig, H, Frech, C, Kauer, M, Windhager, R, Kitzinger, H, Tzou, C-H, Gerner, C, Ambros, PF & Ambros, IA 2017, 'The human repair Schwann cell phenotype - OMIC analyses identified novel proteins and functions involved in nerve regeneration', Glia, Jg. 65, S. E515-E516.

Taschner-Mandl, S, Weiss, T, Berner, J, Bileck, A, Rifatbegovic, F, Windhager, R, Kitzinger, H, Tzou, C-H, Ambros, IA, Gerner, C, Dohnal, A & Ambros, PF 2017, 'The immune-regulatory role of human primary repair and tumor-associated Schwann cells', Glia, Jg. 65, S. E495-E495.

Bachmayr-Heyda, A, Aust, S, Auer, K, Meier, SM, Schmetterer, KG, Dekan, S, Gerner, C & Pils, D 2017, 'Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer', Clinical Cancer Research, Jg. 23, Nr. 8, S. 2081-2092. https://doi.org/10.1158/1078-0432.CCR-16-1647





Mayer, RL, Slany, A, Bileck, A, Agis, H, Schwarzmeier, JD & Gerner, C 2017, 'Proteomic Comparison of B-cell Malignancies – Chronic Lymphocytic Leukemia and Multiple Myeloma', Wien, Österreich, 16/02/17 - 17/02/17, .




Gschwandtner, M, Paulitschke, V, Mildner, M, Brunner, PM, Hacker, S, Eisenwort, G, Sperr, WR, Valent, P, Gerner, C & Tschachler, E 2017, 'Proteome analysis identifies L1CAM/CD171 and DPP4/CD26 as novel markers of human skin mast cells', Allergy: European journal of allergy and immunology, Jg. 72, Nr. 1, S. 85-97. https://doi.org/10.1111/all.12919



Weiss, T, Taschner-Mandl, S, Bileck, A, Slany, A, Kromp, F, Rifatbegovic, F, Frech, C, Windhager, R, Kitzinger, H, Tzou, C-H, Ambros, PF, Gerner, C & Ambros, IM 2016, 'Proteomics and Transcriptomics of Peripheral Nerve Tissue and Cells Unravel New Aspects of the Human Schwann Cell Repair Phenotype', Glia, Jg. 64, Nr. 12, S. 2133-2153. https://doi.org/10.1002/glia.23045







Auer, K, Bachmayr-Heyda, A, Sukhbaatar, N, Aust, S, Schmetterer, KG, Meier, SM, Gerner, C, Grimm, C, Horvat, R & Pils, D 2016, 'Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer', Onco Target, Jg. 7, Nr. 38, S. 61336-61354.


Mayer, RL, Slany, A, Bileck, A, Agis, H, Schwarzmeier, JD & Gerner, C 2016, 'Proteomic Comparison of B-cell Malignancies – Chronic Lymphocytic Leukemia and Multiple Myeloma', Heidelberg, Deutschland, 14/09/16 - 17/09/16, .

Bileck, A, Ribitsch, I, Mayer, RL, Jenner, F & Gerner, C 2016, 'Tendon Repair Processes Analyzed by High Resolution Mass Spectrometry: Lessons to Learn from Fetal Healing', Heidelberg, Deutschland, 14/09/16 - 17/09/16, .

Paulitschke, V, Eichhoff, O, Gerner, C, Kunstfeld, R, Pehamberger, H, Dummer, R & Levesque, M 2016, 'Evaluation of Resistance Mechanisms in Melanoma by means of Proteome Analysis', Journal der Deutschen Dermatologischen Gesellschaft, Jg. 14, S. 14-14.




Meier, SM, Langbauer, C, Raible, F & Gerner, C 2016, 'Reproducible quantification of metabolites from fingertips via triple-quadrupole mass spectrometry' Beitrag in, Wien, Österreich, 8/05/16 - 10/05/16, .


Meshcheryakova, A, Svoboda, M, Tahir, A, Koefeler, HC, Triebl, A, Mungenast, F, Heinze, G, Gerner, C, Zimmermann, P, Jaritz, M & Mechtcheriakova, D 2016, 'Exploring the role of sphingolipid machinery during the epithelial to mesenchymal transition program using an integrative approach', Onco Target, Jg. 7, Nr. 16, S. 22295-22323. https://doi.org/10.18632/oncotarget.7947






Putz, EM, Majoros, A, Gotthardt, D, Prchal-Murphy, M, Zebedin-Brandl, EM, Fux, DA, Schlattl, A, Schreiber, RD, Carotta, S, Mueller, M, Gerner, C, Decker, T & Sexl, V 2016, 'Novel non-canonical role of STAT1 in Natural Killer cell cytotoxicity', OncoImmunology, Jg. 5, Nr. 9, 1186314. https://doi.org/10.1080/2162402X.2016.1186314




Ribitsch, I, Gerner, C, Kreil, D, Rosser, J, Gabner, S, Egerbacher, M & Jenner, F 2015, 'Fetal Regeneration versus Adult Repair - Lessons to Learn from Fetal Healing', Tissue engineering. Part A, Jg. 21, S. S7-S7.



Al-Serori, H, Ferk, F, Koller, VJ, Bileck, A, Gerner, C, Gminski, R, Angerer, V, Auwaerter, V & Knasmueller, S 2015, 'Does Consumption of Synthetic Cannabinoids Cause Genetic Damage in Drug Users?', Environmental and Molecular Mutagenesis, Jg. 56, S. S64-S64.




Meier, SM, Kreutz, D, Mader, J, Heffeter, P, Berger, W, Hartinger, CG, Keppler, B & Gerner, C 2015, 'Chemical Proteomics and Protein Profiling to Unravel the Molecular Mechanism of Action of an Orally Active Organometallic Drug Candidate', Reading, Großbritannien / Vereinigtes Königreich, 20/07/15 - 22/07/15, .

Bileck, A, Slany, A, Kreutz, D & Gerner, C 2015, Evaluation of signalling pathways in primary human peripheral blood mononuclear cells by in-depth proteome profiling. in Book of Abstracts., Reading, Großbritannien / Vereinigtes Königreich, 20/07/15.

Kreutz, D, Bileck, A, Meier, SM, Keppler, B & Gerner, C 2015, 'Investigation of novel metal-based anticancer drug candidates’ mechanisms of action by in-depth proteome profiling.', Reading, Großbritannien / Vereinigtes Königreich, 20/07/15 - 22/07/15, .

Gerner, C, Bileck, A, Kreutz, D, Muqaku, B, Mayer, RL & Slany, A 2015, Proteome signatures of inflammatory primary human mesenchymal cells. in Book of Abstracts., Reading, Großbritannien / Vereinigtes Königreich, 20/07/15.

Bayer, N, Hizal, S, Bileck, A, Kreutz, D, Mader, J & Gerner, C 2015, 'Towards a comprehensive membrane proteome profiling technique', Reading, Großbritannien / Vereinigtes Königreich, 20/07/15 - 22/07/15, .



Mayer, RL, Meier, SM, Langbauer, C & Gerner, C 2015, Reproducible Quantification of Metabolites from Fingertips via Triple-Quadrupole Mass Spectrometry. in Book of Abstracts., Innsbruck, Österreich, 12/06/15.

Karlic, H, Thaler, R, Gerner, C, Grunt, T, Proestling, K, Haider, F & Varga, F 2015, 'Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells', Cancer Genetics, Jg. 208, Nr. 5, S. 241-252. https://doi.org/10.1016/j.cancergen.2015.03.008

Mayer, RL, Slany, A, Bileck, A, Kreutz, D, Gerner, C & Schwarzmeier, JD 2015, 'Ultra-Deep Mass Spectrometry-based Proteomics Enables New Insights into Chronic Lymphocytic Leukemia', Salzburg, Österreich, 23/04/15 - 25/04/15, .




Gschwandtner, M, Paulitschke, V, Berger, T, Tschachler, A, Mildner, M, Gerner, C & Tschachler, E 2015, 'Proteome analysis of primary human skin mast cells', Experimental Dermatology, Jg. 24, Nr. 3, S. E7-E7.

Paulitschke, V, Berger, W, Paulitschke, P, Hofstaetter, E, Knapp, B, Dingelmaier-Hovorka, R, Foedinger, D, Jäger, W, Szekeres, T, Meshcheryakova, A, Bileck, A, Pirker, C, Pehamberger, H, Gerner, C & Kunstfeld, R 2015, 'Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts', Molecular Cancer Therapeutics, Jg. 14, Nr. 3, S. 757-768. https://doi.org/10.1158/1535-7163.MCT-14-0701


Paulitschke, V, Gerner, C, Hofstaetter, E, Mohr, T, Mayer, RL, Pehamberger, H & Kunstfeld, R 2015, 'Proteome profiling of keratinocytes transforming to malignancy', Electrophoresis, Jg. 36, Nr. 4, S. 564-576. https://doi.org/10.1002/elps.201400309

Meshcheryakova, A, Svoboda, M, Koefeler, HC, Triebl, A, Mungenast, F, Tahir, A, Gerner, C, Zimmermann, P, Jaritz, M & Mechtcheriakova, D 2015, 'Sphingolipid machinery in EMT: From a cell-based model to pathobiology of lung cancer', International Journal of Molecular Medicine, Jg. 36, S. S43-S43.



Veitinger, M, Oehler, R, Umlauf, E, Baumgartner, R, Schmidt, G, Gerner, C, Babeluk, R, Attems, J, Mitulovic, G, Rappold, E, Lamont, J & Zellner, M 2014, 'A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype', Acta Neuropathologica, Jg. 128, Nr. 5, S. 665-677. https://doi.org/10.1007/s00401-014-1341-8



Muqaku, B, Bileck, A, Kreutz, D, Mayer, RL, Slany, A & Gerner, C 2014, Can MRM-based secretome profiling be used as drug evaluation assay? in Book of Abstracts. S. 336, Madrid, Spanien, 5/10/14.




Gerner, C, Weiss, T, Bileck, A, Slany, A, Kreutz, D, Taschner, S, Ambros, IM & Ambros, PF 2014, 'Schwannomics: Profiling Schwann cells as potential prototype for tumor-inhibiting stromal cells' Beitrag in, Salzburg, Österreich, 22/09/14 - 24/09/14, .

Muqaku, B, Bileck, A, Kreutz, D, Mayer, RL, Slany, A & Gerner, C 2014, 'MRM-based quantitative secretome analysis of inflammatory activated primary human cells' Beitrag in, Salzburg, Österreich, 22/09/14 - 24/09/14, .

Bileck, A, Slany, A, Größl, M, Kreutz, D, Gloessmann, K, Pfeiler, G & Gerner, C 2014, 'Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts' Beitrag in, Salzburg, Österreich, 22/09/14 - 24/09/14, .



Meier, SM, Muqaku, B, Ullmann, R, Knasmüller, S & Gerner, C 2014, 'Insights into the Modulation of Inflammatory Processes by a Natural Extract of Mucor Racemosus', Salzburg, Österreich, 22/09/14 - 24/09/14, .


Mayer, R, Slany, A, Bileck, A, Kreutz, D, Schwarzmeier, JD & Gerner, C 2014, 'Revealing the Achilles heel of chronic lymphocytic leukemia by proteome analysis of primary leukemia cells', Salzburg, Österreich, 22/09/14 - 24/09/14, .











Klepeisz, P, Sagmeister, S, Haudek-Prinz, V, Pichlbauer, M, Grasl-Kraupp, B & Gerner, C 2013, 'Phenobarbital Induces Alterations in the Proteome of Hepatocytes and Mesenchymal Cells of Rat Livers', PLoS ONE, Jg. 8, Nr. 10, 76137. https://doi.org/10.1371/journal.pone.0076137

Wolrab, D, Bileck, A, Slany, A & Gerner, C 2013, Assessment of drug effects exemplified by activated PBMCs treated with Aspirin and Dexamethasone, respectively. in Book of Abstracts of the1st International Symposium on Profiling., Lissabon, Portugal, 2/09/13.

Slany, A, Bileck, A, Agis, H & Gerner, C 2013, Characterization of the tumor-promoting effect of stromal cells in multiple myeloma by proteome profiling. in Book of Abstracts of the1st International Symposium on Profiling., Lissabon, Portugal, 2/09/13.

Mayer, R, Muqaku, B, Bileck, A, Slany, A, Größl, M & Gerner, C 2013, How close to completeness are we regarding proteome profiling of primary human cells? in Book of Abstracts of the1st International Symposium on Profiling., Lissabon, Portugal, 2/09/13.

Gerner, C, Tahir, A, Bileck, A, Größl, M & Slany, A 2013, Investigation of drug effects by the combination of proteomics and lipidomics. in Book of Abstracts of the1st International Symposium on Profiling., Lissabon, Portugal, 2/09/13.

Bileck, A, Slany, A, Agis, H & Gerner, C 2013, Proteome Profiling of primary human multiple myeloma cells in comparison to the established multiple myeloma cell line RPMI-8226. in Book of Abstracts of the1st International Symposium on Profiling., Lissabon, Portugal, 2/09/13.

Muqaku, B, Mayer, R, Slany, A & Gerner, C 2013, Quantitative proteomics of the chemokine IL-8 applying orbitrap and triple quadrupole mass spectrometer. in Book of Abstracts of the1st International Symposium on Profiling., Lissabon, Portugal, 2/09/13.

Reichle, A, Gerner, C & Haegeman, G 2013, Criticizable claims for the validity of communication acts in biological systems: Therapeutic implications in cancer. in Evolution-adjusted Tumor Pathophysiology: The Novel Language of Tumor Biology. Springer Netherlands, S. 169-187. https://doi.org/10.1007/978-94-007-6866-6_11

Paulitschke, V, Gruber, S, Hofstätter, E, Haudek-Prinz, V, Klepeisz, P, Schicher, N, Jonak, C, Petzelbauer, P, Pehamberger, H, Gerner, C & Kunstfeld, R 2013, Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction. in Evolution-adjusted Tumor Pathophysiology: The Novel Language of Tumor Biology. Springer Netherlands, S. 101-141. https://doi.org/10.1007/978-94-007-6866-6_8


Michael, C, Gerner, C & Rizzi, A 2013, 'PGC-µLc-ESI-QqTOF-MS for Quantitative Glycan Analysis', Palermo, Italien, 5/05/13 - 8/05/13, .

Paulitschke, V, Haudek-Prinz, V, Griss, J, Berger, W, Mohr, T, Pehamberger, H, Gerner, C & Kunstfeld, R 2013, 'Identification of a drug resistance signature by proteome analysis', Journal of Investigative Dermatology, Jg. 133, Nr. Suppl.1, S. 236-236.

Campregher, C, Schmid, G, Ferk, F, Knasmueller, S, Khare, V, Kortuem, B, Dammann, K, Lang, M, Scharl, T, Spittler, A, Roig, AI, Shay, JW, Gerner, C & Gasche, C 2012, 'MSH3-Deficiency Initiates EMAST without Oncogenic Transformation of Human Colon Epithelial Cells', PLoS ONE, Jg. 7, Nr. 11, 50541. https://doi.org/10.1371/journal.pone.0050541

Veitinger, M, Umlauf, E, Baumgartner, R, Badrnya, S, Porter, J, Lamont, J, Gerner, C, Gruber, CW, Oehler, R & Zellner, M 2012, 'A combined proteomic and genetic analysis of the highly variable platelet proteome: From plasmatic proteins and SNPs', Journal of Proteomics, Jg. 75, Nr. 18, S. 5848-5860. https://doi.org/10.1016/j.jprot.2012.07.042

Weichhart, T, Kopecky, C, Kubicek, M, Haidinger, M, Döller, D, Katholnig, K, Suarna, C, Eller, P, Tölle, M, Gerner, C, Zlabinger, GJ, Van Der Giet, M, Hörl, WH, Stocker, R & Säemann, MD 2012, 'Wenn "gutes" cholesterin böse wird', Vasomed, Jg. 24, Nr. 2, S. 95-96.

Zellner, M, Baureder, M, Rappold, E, Bugert, P, Kotzailias, N, Babeluk, R, Baumgartner, R, Attems, J, Gerner, C, Jellinger, K, Roth, E, Oehler, R & Umlauf, E 2012, 'Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients', Journal of Proteomics, Jg. 75, Nr. 7, S. 2080-2092. https://doi.org/10.1016/j.jprot.2012.01.014





Haudek-Prinz, V, Klepeisz, P, Slany, A, Griss, J, Meshcheryakova, A, Paulitschke, V, Mitulovic, G, Stöckl, J & Gerner, C 2012, 'Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells', Journal of Proteomics, Jg. 76, Nr. SI, S. 150-162. https://doi.org/10.1016/j.jprot.2012.07.012




Weichhart, T, Kopecky, C, Kubicek, M, Haidinger, M, Doeller, D, Katholnig, K, Suarna, C, Eller, P, Tölle, M, Gerner, C, Zlabinger, G-J, van der Giet, M, Hörl, WH & Stocker, R 2012, 'Serum Amyloid A in Uremic HDL Promotes Inflammation', Journal of the American Society of Nephrology (JASN), Jg. 23, Nr. 5, S. 934-947. https://doi.org/10.1681/ASN.2011070668


Slany, A, Haudek, VJ, Zwickl, H, Gundacker, NC, Grusch, M, Weiss, TS, Seir, K, Rodgarkia-Dara, C, Hellerbrand, C & Gerner, C 2010, 'Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B', Journal of Proteome Research, Jg. 9, Nr. 1, S. 6-21. https://doi.org/10.1021/pr900057t



Gundacker, NC, Haudek, VJ, Wimmer, H, Slany, A, Griss, J, Bochkov, V, Zielinski, C, Wagner, O, Stöckl, J & Gerner, C 2009, 'Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells', Journal of Proteome Research, Jg. 8, Nr. 6, S. 2799-2811. https://doi.org/10.1021/pr8011039

Wimmer, H, Gundacker, NC, Griss, J, Haudek, VJ, Staettner, S, Mohr, T, Zwickl, H, Paulitschke, V, Baron, DM, Trittner, W, Kubicek, M, Bayer, E, Slany, A & Gerner, C 2009, 'Introducing the CPL/MUW proteome database: Interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells', Electrophoresis, Jg. 30, Nr. 12, S. 2076-2089. https://doi.org/10.1002/elps.200900072


Slany, A, Haudek, VJ, Gundacker, NC, Griss, J, Mohr, T, Wimmer, H, Eisenbauer, M, Elbling, L & Gerner, C 2009, 'Introducing a new parameter for quality control of proteome profiles: Consideration of commonly expressed proteins', Electrophoresis, Jg. 30, Nr. 8, S. 1306-1328. https://doi.org/10.1002/elps.200800440


Curriculum vitae
Prof. Dr. Christopher Gerner
Current positions:
• Debuty head of the Department of Analytical Chemistry
• Deputy head of the Centre for Mass Spectrometry at the Faculty of Chemistry
• Deputy head of the Research Platform "Marine Rhythms of Life"
• Deputy head of the Karl Landsteiner Institute of Bioanalytical Oncology
Higher education:
2002 Venia docendi for Oncologic Biochemistry, University of Vienna
1998 PhD for Biochemistry at University of Vienna
1993 MSc for Chemistry at University of Vienna
Academic appointments and professional experience:
Since 2012 Full Professor for Separation Technologies and Bioanalysis at University of Vienna
2009 Visiting Scientist at the Diamantine Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Australia
2003-2012 Group leader of the Clinical Proteomics Laboratories at the Medical University of Vienna
2002 Post-Doc in the group of Prof. Seamus Martin, Trinity College, Dublin, Ireland
2001 Visiting scientist in the group of Prof. Gerald Cohen, University of Leicester, GB.
1998-2001 Post-Doc in the group of Prof. Rolf Schulte-Hermann, Department of Toxicology, University of Vienna
1997 UN Officer (degree: Major) and Acting Chief Inspector for Chemical Team at UNSCOM, Baghdad, Iraq
1995-1998 Research Assistant at the Institute of Cancer Research, Vienna
Research activities
Bioanalysis largely based on various forms of chromatography hyphenated with mass spectrometry focussing on the development of novel methods for investigating patho-mechanisms and drug effects in humans. A combined analysis of proteins, lipids and metabolites is applied for providing new insights into processes such as inflammation, cancer and tissue regeneration. New methods are established supporting easy and reliable sampling of human individuals such as fingersweat analyses for individual profiling.
Key papers
1. Muqaku, B.; Eisinger, M.; Meier, S. M.; Tahir, A.; Pukrop, T.; Haferkamp, S.; Slany, A.; Reichle, A.; Gerner, C., Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma. Mol Cell Proteomics 2017, 16, (1), 86-99.
2. Tahir, A.; Bileck, A.; Muqaku, B.; Niederstaetter, L.; Kreutz, D.; Mayer, R. L.; Wolrab, D.; Meier, S. M.; Slany, A.; Gerner, C., Combined Proteome and Eicosanoid Profiling Approach for Revealing Implications of Human Fibroblasts in Chronic Inflammation. Anal Chem 2017, 89, (3), 1945-1954.
3. Kreutz, D.; Bileck, A.; Plessl, K.; Wolrab, D.; Groessl, M.; Keppler, B. K.; Meier, S. M.; Gerner, C., Response Profiling Using Shotgun Proteomics Enables Global Metallodrug Mechanisms of Action To Be Established. Chemistry 2017, 23, (8), 1881-1890.

Proteomic profiling reveals molecular cell responses to deoxynivalenol treatment in human A431 epidermoid squamous carcinoma cells

Giorgia Del Favero (VortragendeR), Lukas Janker (AutorIn), Benjamin Neuditschko (AutorIn), Julia Hohenbichler (AutorIn), Lydia Wölflingseder (AutorIn), Christopher Gerner (AutorIn), Doris Marko (AutorIn)
25 Apr 2019

Aktivität: VorträgeVortragScience to Science


Deoxynivalenol and A431 epidermoid squamous carcinoma cells: proteomic profiling reveals the pathways connecting ribosomal inhibition with a loss of function of the cell membrane

Lukas Janker (VortragendeR), Benjamin Neuditschko (AutorIn), Julia Hohenbichler (AutorIn), Lydia Wölflingseder (AutorIn), Christopher Gerner (AutorIn), Doris Marko (AutorIn), Giorgia Del Favero (AutorIn)
19 Feb 2019

Aktivität: VorträgeVortragScience to Science


Metabolomics, lipidomics and proteomics unravel the role of neutrophils for ovarian cancer and melanoma metastases

Christopher Gerner (Invited speaker)
6 Dez 2018

Aktivität: VorträgeVortragScience to Science


Cold induced eicosanoid signature differs between BAT positive and BAT negative subjects

Laura Niederstätter (VortragendeR), Oana C. Hedesan (AutorIn), Carsten Herz (AutorIn), Alexander R. Haug (AutorIn), Christopher Gerner (AutorIn), Florian W. Kiefer (AutorIn)
29 Aug 2018

Aktivität: VorträgeVortragScience to Science


In-depth proteome profiling of primary human myeloma cells: new insights into hypoxia driven metabolic, anti-apoptotic and immune evasion strategies

Astrid Slany (VortragendeR), Lukas Janker (AutorIn), Rupert Laurenz Mayer (AutorIn), Andrea Bileck (AutorIn), Dominique Kreutz (AutorIn), Johanna Mader (AutorIn), Hermine Agis (AutorIn), Christopher Gerner (AutorIn)
29 Aug 2018

Aktivität: VorträgeVortragScience to Science


Unravelling the effect of deoxynivalenol on A431 cells: Proteome profiling and imaging

Giorgia Del Favero (VortragendeR), Lukas Janker (AutorIn), Benjamin Neuditschko (AutorIn), Lydia Wölflingseder (AutorIn), Christopher Gerner (AutorIn), Doris Marko (AutorIn)
6 Jul 2018

Aktivität: VorträgeVortragScience to Science


The power of integrative multi-omics analyses for diagnostic and prognostic purposes

Christopher Gerner (Invited speaker)
24 Mai 2018

Aktivität: VorträgeVortragScience to Science


Curcumin exerts its antitumor effects in a context dependent fashion

Lukas Janker (VortragendeR), Dominique Kreutz (AutorIn), Chomdao Sinthuvanich (AutorIn), Andrea Bileck (AutorIn), Astrid Slany (AutorIn), Christopher Gerner (AutorIn)
4 Mai 2018

Aktivität: VorträgeVortragScience to Science


Evaluation of individual metabolic parameters by the analysis of finger sweat samples using liquid chromatography‐mass spectrometry

Julia Brunmair (VortragendeR), Christopher Gerner (AutorIn), Laura Niederstätter (AutorIn)
4 Mai 2018

Aktivität: VorträgeVortragScience to Science


Image analysis and proteomic profiling: complementary tools for toxicity studies

Giorgia Del Favero (VortragendeR), Lydia Wölflingseder (AutorIn), Lukas Janker (AutorIn), Benjamin Neuditschko (AutorIn), Christopher Gerner (AutorIn), Doris Marko (AutorIn)
4 Mai 2018

Aktivität: VorträgeVortragScience to Science


Response Profiling of the anti‐cancer drug arsenic trioxide

Benjamin Neuditschko (VortragendeR), Christopher Gerner (AutorIn)
4 Mai 2018

Aktivität: VorträgeVortragScience to Science


Integrative Metabolomics with Impact on Survival in Serous Ovarian Cancer

Christopher Gerner (VortragendeR)
19 Apr 2018

Aktivität: VorträgeVortragScience to Science


Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia

Christopher Gerner (Invited speaker)
21 Mär 2018

Aktivität: VorträgeVortragScience to Science


Aging-related proteome alterations in B cells may predispose for chronic lymphocytic leukemia

Rupert Laurenz Mayer (VortragendeR), Astrid Slany (AutorIn), Andrea Bileck (AutorIn), Johanna Mader (AutorIn), Samuel Matthias Meier (AutorIn), Tobias Pukrop (AutorIn), Albrecht Reichle (AutorIn), Josef D. Schwarzmeier (AutorIn), Christopher Gerner (AutorIn)
6 Sep 2017

Aktivität: VorträgeVortragScience to Science


Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma

Besnik Muqaku (VortragendeR), Martin Eisinger (AutorIn), Samuel Matthias Meier (AutorIn), Ammar Tahir (AutorIn), Tobias Pukrop (AutorIn), Sebastian Haferkamp (AutorIn), Astrid Slany (AutorIn), Albrecht Reichle (AutorIn), Christopher Gerner (AutorIn)
6 Sep 2017

Aktivität: VorträgeVortragScience to Science


On the molecular mechanism of action of organometallic anticancer drugs

Christopher Gerner (VortragendeR), Samuel Matthias Meier (AutorIn), Dominique Kreutz (AutorIn), Tamara Weiss (AutorIn), Andrea Bileck (AutorIn), Bernhard Keppler (AutorIn), Gerhard Wiche (AutorIn)
14 Aug 2017

Aktivität: VorträgeVortragScience to Science


The amazing functional plasticity of platelets investigated by combining proteomics with lipidomics

Christopher Gerner (VortragendeR)
10 Apr 2017

Aktivität: VorträgeVortragScience to Science


Combinatory shotgun proteomics and shotgun eicosadomics study of platelets activated by calcium mobilization

Christopher Gerner (VortragendeR), Ammar Tahir (AutorIn), Rupert Laurenz Mayer (AutorIn), Marie L. Boehm (AutorIn), Andrea Bileck (AutorIn), Besnik Muqaku (AutorIn), Albrecht Reichle (AutorIn), Astrid Slany (AutorIn)
3 Apr 2017

Aktivität: VorträgeVortragScience to Science


Combined proteomics and lipidomics supports the investigation and discovery of novel pathomechanisms

Christopher Gerner (VortragendeR)
12 Jan 2017

Aktivität: VorträgeVortragScience to Science



Institut für Analytische Chemie

Vorstand

Währinger Straße 38
1090 Wien
Zimmer: 1220

T: +43-1-4277-52302
F: +43-1-4277-852302

christopher.gerner@univie.ac.at